Lv3
373 积分 2021-03-23 加入
Cardiovascular Outcomes Research A Clinician’s Guide to Cardiovascular Epidemiology and Clinical Outcomes Trials
1天前
已完结
The story of amylin: from physiology to therapy
6天前
已完结
Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies
7天前
已完结
Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
24天前
已关闭
Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study
24天前
已关闭
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial
1个月前
已完结
Incretin therapy for cardiovascular disease: opportunities, mechanistic gaps, and challenges
3个月前
已完结
MASLD, MASH, and the CKM Spectrum
3个月前
已完结
Incretin therapy for cardiovascular disease: opportunities, mechanistic gaps, and challenges
3个月前
已关闭
Unintended risks of sarcopenic obesity during weight-loss interventions in older people
3个月前
已完结
皖公网安备34019202002308
